BIOX Overview

Real-time Intelligence: Benzinga Pro offers traders the fastest news alerts to stay updated on market movements.

Exclusive Stories: The platform provides unique stories generated by Benzinga reporters, enhancing trading insights.

Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing valuable market intelligence.

Market Winning Tool: Benzinga Pro is designed to help traders succeed in the markets by providing accurate and timely information.

Quarterly Performance: Bioceres Crop (BIOX) reported a quarterly loss of $0.12 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.04, and revenues of $77.3 million, missing estimates by 18.37%.

Stock Outlook: The company's shares have declined by 68.3% this year, contrasting with the S&P 500's 16.4% gain, but current favorable earnings estimate revisions have resulted in a Zacks Rank #2 (Buy) for the stock.

Industry Context: Bioceres operates in the Agriculture - Operations industry, which is currently ranked in the bottom 20% of Zacks industries, indicating potential challenges ahead for stock performance.

Upcoming Reports: Another industry player, Cibus (CBUS), is set to report its quarterly results on November 13, with expectations of a significant loss and declining revenues compared to the previous year.

Financial Performance: Bioceres Crop Solutions reported total revenues of $77.5 million in 1Q26, a 17% decline year-over-year, with a net loss of $7.5 million and an Adjusted EBITDA of $13.6 million, reflecting a 61% increase from the previous year.

Operational Improvements: Despite lower revenues, the company achieved a gross profit of $36.2 million, with gross margin expanding to 47% due to a more profitable product mix and reduced operating expenses.

Management Insights: CEO Federico Trucco highlighted progress in improving revenue quality, protecting margins, and maintaining cost discipline, while acknowledging ongoing challenges in the Argentine market.

Strategic Focus: Bioceres is prioritizing actions to strengthen its capital structure and enhance financial flexibility, aiming for long-term resilience through improved margin quality and working-capital efficiency.